年筛查未获推荐的吸烟者肺癌风险评估
本研究利用心血管健康研究(CHS)队列中4279名无癌症基线数据的老年人,分析美国预防服务工作组不推荐年度低剂量CT筛查的两类吸烟者(戒烟≥15年的既往吸烟者及<20包年的当前吸烟者)的肺癌风险。中位随访13.3年,这两类人群肺癌发生风险显著高于从不吸烟者,年龄、性别、种族校正后HR分别为10.22和10.06。作者认为需要预测模型来识别其中高风险亚组以进行筛查。
要点
- 戒烟≥15年且≥20包年的既往吸烟者肺癌风险显著高于从不吸烟者,校正后HR为10.22(95%CI 4.86-21.50)。
- <20包年的当前吸烟者肺癌风险显著高于从不吸烟者,校正后HR为10.06(95%CI 3.41-29.70)。
- 作者认为需要预测模型识别这些吸烟者中的高风险亚组以进行筛查。
核心结论
- 这项队列研究提示,美国预防服务工作组不推荐年度低剂量CT筛查的吸烟者(戒烟≥15年且≥20包年的既往吸烟者及<20包年的当前吸烟者)肺癌风险高。
- 作者认为需要预测模型来识别这些吸烟者中的高风险亚组以进行筛查。
研究设计与样本
- 这项队列研究使用美国国家心肺血液研究所赞助的心血管健康研究(CHS)数据集。
- CHS于1989年6月至1993年6月在美国纳入5888名65岁及以上社区居住个体,并收集了详细的基线吸烟史数据。
- 当前分析仅纳入4279名无癌症且具有基线包年吸烟史和戒烟时长数据的个体。
- 当前分析于2022年1月7日至2022年5月25日进行。
- 暴露为当前和既往烟草使用。
主要发现
- 中位(IQR)随访13.3(7.9-18.8)年(范围0至22.6年),截至2011年12月31日。
- 4279名CHS参与者平均(SD)年龄72.8(5.6)岁;2450名(57.3%)为女性;663名(15.5%)为非裔美国人,3585名(83.8%)为白人,31名(0.7%)为其他种族或族裔。
- 在861名非重度吸烟者(<20包年)中,615名戒烟≥15年的既往吸烟者中位(IQR)包年吸烟史为7.6(3.3-13.5)包年,146名戒烟<15年的既往吸烟者为10.0(5.3-14.9)包年,100名当前吸烟者为11.4(7.3-14.4)包年。
- 在1445名重度吸烟者(≥20包年)中,516名戒烟≥15年的既往吸烟者中位(IQR)包年吸烟史为34.8(26.3-48.0)包年,497名戒烟<15年的既往吸烟者为48.0(35.0-70.0)包年,432名当前吸烟者为48.8(31.6-57.0)包年。
- 发生肺癌者包括1973名从不吸烟者中10名(0.5%)、100名<20包年当前吸烟者中5名(5.0%)、516名戒烟≥15年且≥20包年既往吸烟者中26名(5.0%)。
关键数值与推荐
- 与从不吸烟者相比,低剂量CT筛查未获推荐的两组中,<20包年当前吸烟者的病因特异性HR为10.54(95%CI 3.60-30.83)。
- 与从不吸烟者相比,戒烟≥15年且≥20包年既往吸烟者的病因特异性HR为11.19(95%CI 5.40-23.21)。
- 年龄、性别、种族校正后,<20包年当前吸烟者与从不吸烟者相比的HR为10.06(95%CI 3.41-29.70)。
- 年龄、性别、种族校正后,戒烟≥15年且≥20包年既往吸烟者与从不吸烟者相比的HR为10.22(95%CI 4.86-21.50)。
临床怎么用
- 原文未据此给出推荐。
- 作者认为需要预测模型来识别低剂量CT筛查未获推荐的吸烟者中的高风险亚组以进行筛查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The US Preventive Services Task Force does not recommend annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who are former smokers with 20 or more pack-years of smoking who quit 15 or more years ago or current smokers with less than 20 pack-years of smoking. OBJECTIVE: To determine the risk of lung cancer in older smokers for whom LDCT screening is not recommended. DESIGN, SETTINGS, AND PARTICIPANTS: This cohort study used the Cardiovascular Health Study (CHS) data sets obtained from the National Heart, Lung and Blood Institute, which also sponsored the study. The CHS enrolled 5888 community-dwelling individuals aged 65 years and older in the US from June 1989 to June 1993 and collected extensive baseline data on smoking history. The current analysis was restricted to 4279 individuals free of cancer who had baseline data on pack-year smoking history and duration of smoking cessation. The current analysis was conducted from January 7, 2022, to May 25, 2022. EXPOSURES: Current and prior tobacco use. MAIN OUTCOMES AND MEASURES: Incident lung cancer during a median (IQR) of 13.3 (7.9-18.8) years of follow-up (range, 0 to 22.6) through December 31, 2011. A Fine-Gray subdistribution hazard model was used to estimate incidence of lung cancer in the presence of competing risk of death. Cox cause-specific hazard regression models were used to estimate hazard ratios (HRs) and 95% CIs for incident lung cancer. RESULTS: There were 4279 CHS participants (mean [SD] age, 72.8 [5.6] years; 2450 [57.3%] women; 663 [15.5%] African American, 3585 [83.8%] White, and 31 [0.7%] of other race or ethnicity) included in the current analysis. Among the 861 nonheavy smokers (<20 pack-years), the median (IQR) pack-year smoking history was 7.6 (3.3-13.5) pack-years for the 615 former smokers with 15 or more years of smoking cessation, 10.0 (5.3-14.9) pack-years for the 146 former smokers with less than 15 years of smoking cessation, and 11.4 (7.3-14.4) pack-years for the 100 current smokers. Among the 1445 heavy smokers (20 or more pack-years), the median (IQR) pack-year smoking history was 34.8 (26.3-48.0) pack-years for the 516 former smokers with 15 or more years of smoking cessation, 48.0 (35.0-70.0) pack-years for the 497 former smokers with less than 15 years of smoking cessation, and 48.8 (31.6-57.0) pack-years for the 432 current smokers. Incident lung cancer occurred in 10 of 1973 never smokers (0.5%), 5 of 100 current smokers with less than 20 pack-years of smoking (5.0%), and 26 of 516 former smokers with 20 or more pack-years of smoking with 15 or more years of smoking cessation (5.0%). Compared with never smokers, cause-specific HRs for incident lung cancer in the 2 groups for whom LDCT is not recommended were 10.54 (95% CI, 3.60-30.83) for the current nonheavy smokers and 11.19 (95% CI, 5.40-23.21) for the former smokers with 15 or more years of smoking cessation; age, sex, and race-adjusted HRs were 10.06 (95% CI, 3.41-29.70) for the current nonheavy smokers and 10.22 (4.86-21.50) for the former smokers with 15 or more years of smoking cessation compared with never smokers. CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that there is a high risk of lung cancer among smokers for whom LDCT screening is not recommended, suggesting that prediction models are needed to identify high-risk subsets of these smokers for screening.
引用
- Faselis C, Nations JA, Morgan CJ, et al. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended. JAMA Oncol. 2022. PMID: 35900734. doi:10.1001/jamaoncol.2022.2952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。